# Fitness Training for γδ T cells in mouse and human atherosclerosis takes place in plaques and artery tertiary lymphoid organs

**Authors:** Zhihua Wang, Ting Sun, Yixin Zhang, Yutao Li, Chuankai Zhang, Xinwen Dou, Xinyi Deng, Zhipeng Li, Jingpu Zhu, Mingyang Hong, Yi Ran, Shu Wang, Liping Li, Junjie Zheng, Cong Wen, Xi Zhang, Shu Lu, Sagar, Sarajo K. Mohanta, Andreas J.R. Habenicht, Changjun Yin

PMC · DOI: 10.1186/s13073-026-01613-1 · Genome Medicine · 2026-02-24

## TL;DR

γδ T cells are found in mouse atherosclerosis plaques and lymphoid organs, where they become specialized and expand, but are less common and more cytotoxic in human plaques.

## Contribution

The study reveals species-specific differences in γδ T cell function and localization in atherosclerosis, emphasizing the role of local microenvironments.

## Key findings

- γδ T17 cells expand clonally and adopt an anti-apoptotic, tissue-resident phenotype in mouse atherosclerosis.
- Human atherosclerotic plaques contain fewer γδ T cells, dominated by cytotoxic subtypes.
- Spatial transcriptomics shows γδ T cells localize in artery tertiary lymphoid organs near T and B cell zones.

## Abstract

γδ T cells represent a heterogeneous family of innate-like lymphocytes with adaptive immunity features. Although abundant in barrier tissues such as skin and intestine, γδ T cells are rare in the cardiovascular system, which severely limits exploration of their roles in atherosclerosis. Consequently, the spatial localization, functional states, and antigen-driven responses of γδ T cells within atherosclerotic lesions remain poorly defined.

To nevertheless examine γδ T cells in atherosclerosis, we employed an integrative, three-pronged strategy combining γδ T cell single-cell RNA sequencing (scRNA-seq) and single-cell T cell receptor sequencing (scTCR-seq), spatial transcriptomics, and large-scale multi-dataset scRNA-seq integration across multiple hyperlipidemic mouse models. Large-scale multi-dataset scRNA-seq integration was also applied to human atherosclerotic plaque datasets.

We found significant enrichment of γδ T cells within both atherosclerotic plaques and artery tertiary lymphoid organs (ATLOs), particularly of the proinflammatory IL17-producing γδ T17 subtype. Unexpectedly, γδ T17 cells containing paired Vγ6Vδ4 TCR chains with identical complementarity-determining region 3 (CDR3) sequences underwent clonal expansion in atherosclerotic plaques and ATLOs. Transcriptomic analysis revealed that plaques and ATLOs locally educate γδ T17 cells - here termed γδ eduT17 cells - towards an anti-apoptotic, tissue-resident, and apparent hypofunctional phenotype. Furthermore, γδ eduT17 cells underwent metabolic reprogramming within the atherosclerotic microenvironment. Spatial transcriptomics revealed that γδ T cells preferentially localize in ATLOs, particularly at the interface between T cell zones and B cell follicles. Multi-dataset integration confirmed the conservation of these features across multiple hyperlipidemic mouse models. In contrast, human atherosclerotic plaques harbored substantially fewer γδ T cells and the human phenotypes were dominated by an effector/cytolytic γδ T cell subtype, characterized by transcriptomes enriched in cytotoxic effector molecules.

Our findings identify γδ T cells as a previously underappreciated T cell lineage population in atherosclerosis. Murine atherosclerosis is characterized by the enrichment, education, and clonal expansion of proinflammatory γδ eduT17 cells within plaques and ATLOs. In contrast, human plaques harbor γδ T cells with cytolytic features, suggesting divergent roles of γδ T cells between species. These results highlight the importance of local vascular microenvironments in shaping γδ T cell function and emphasize the need for caution when extrapolating mechanistic insights from mouse models to human atherosclerosis.

The online version contains supplementary material available at 10.1186/s13073-026-01613-1.

## Linked entities

- **Diseases:** atherosclerosis (MONDO:0005311)
- **Species:** Mus musculus (taxon 10090), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** AREG (amphiregulin) [NCBI Gene 374] {aka AR, AREGB, CRDGF, SDGF}, ETV5 (ETS variant transcription factor 5) [NCBI Gene 2119] {aka ERM}, Itgae (integrin alpha E, epithelial-associated) [NCBI Gene 16407] {aka A530055J10, CD103, aM290, alpha-E1, alpha-M290}, Il7r (interleukin 7 receptor) [NCBI Gene 16197] {aka CD127, IL-7Ralpha}, TRDC (T cell receptor delta constant) [NCBI Gene 28526] {aka TCRD}, IL7R (interleukin 7 receptor) [NCBI Gene 3575] {aka CD127, CDW127, IL-7R-alpha, IL-7Ralpha, IL7RA, IL7Ralpha}, Sirpa (signal-regulatory protein alpha) [NCBI Gene 19261] {aka Bit, CD172a, Idd13.2, P84, Ptpns1, SHP-1}, TMEM176A (transmembrane protein 176A) [NCBI Gene 55365] {aka GS188, HCA112, MS4B1}, CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348] {aka G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI}, ITGA1 (integrin subunit alpha 1) [NCBI Gene 3672] {aka CD49a, VLA1}, GPAM (glycerol-3-phosphate acyltransferase, mitochondrial) [NCBI Gene 57678] {aka GPAT, GPAT1}, CCR9 (C-C motif chemokine receptor 9) [NCBI Gene 10803] {aka CC-CKR-9, CDw199, GPR-9-6, GPR28}, NPC1 (NPC intracellular cholesterol transporter 1) [NCBI Gene 4864] {aka NPC, POGZ, SLC65A1}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, XCL1 (X-C motif chemokine ligand 1) [NCBI Gene 6375] {aka ATAC, LPTN, LTN, SCM-1, SCM-1a, SCM1}, ALDOA (aldolase, fructose-bisphosphate A) [NCBI Gene 226] {aka ALDA, GSD12, HEL-S-87p}, Klf3 (Kruppel-like transcription factor 3 (basic)) [NCBI Gene 16599] {aka 9930027G08Rik, Bklf, Tef-2}, Flt3 (FMS-like tyrosine kinase 3) [NCBI Gene 14255] {aka B230315G04, CD135, Flk-2, Flk2, Flt-3, Ly72}, BIRC2 (baculoviral IAP repeat containing 2) [NCBI Gene 329] {aka API1, HIAP2, Hiap-2, IAP-2, MIHB, RNF48}, S100A6 (S100 calcium binding protein A6) [NCBI Gene 6277] {aka 2A9, 5B10, CABP, CACY, PRA, S10A6}, ITGAD (integrin subunit alpha D) [NCBI Gene 3681] {aka ADB2, CD11D}, Nfkbia (nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha) [NCBI Gene 18035] {aka Nfkbi}, SPON2 (spondin 2) [NCBI Gene 10417] {aka DIL-1, DIL1, M-SPONDIN, MINDIN}, ACOX1 (acyl-CoA oxidase 1) [NCBI Gene 51] {aka ACOX, AOX, MITCH, PALMCOX, SCOX}, Jund (jun D proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 16478] {aka Jund1}, HADHB (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta) [NCBI Gene 3032] {aka ECHB, MSTP029, MTPB, MTPD, MTPD2, TP-BETA}, Pdcd1 (programmed cell death 1) [NCBI Gene 18566] {aka Ly101, PD-1, Pdc1}, SCART1 (scavenger receptor family member expressed on T cells 1) [NCBI Gene 619207], MCL1 (MCL1 apoptosis regulator, BCL2 family member) [NCBI Gene 4170] {aka BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1}, CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351] {aka ACT2, AT744.1, G-26, HC21, LAG-1, LAG1}, GZMB (granzyme B) [NCBI Gene 3002] {aka C11, CCPI, CGL-1, CGL1, CSP-B, CSPB}, PCSK9 (proprotein convertase subtilisin/kexin type 9) [NCBI Gene 255738] {aka FH3, FHCL3, HCHOLA3, LDLCQ1, NARC-1, NARC1}, Trgc1 (T cell receptor gamma, constant 1) [NCBI Gene 107573] {aka Cgamma1, Gm17004, Tcrg-C1}, CCR6 (C-C motif chemokine receptor 6) [NCBI Gene 1235] {aka BN-1, C-C CKR-6, CC-CKR-6, CCR-6, CD196, CKR-L3}, PGK1 (phosphoglycerate kinase 1) [NCBI Gene 5230] {aka HEL-S-68p, MIG10, PGKA}, BIRC5 (baculoviral IAP repeat containing 5) [NCBI Gene 332] {aka API4, EPR-1}, CCL4L2 (C-C motif chemokine ligand 4 like 2) [NCBI Gene 9560] {aka AT744.2, CCL4L, SCYA4L, SCYQ4L2}, Ldlr (low density lipoprotein receptor) [NCBI Gene 16835] {aka Hlb301}, ACLY (ATP citrate lyase) [NCBI Gene 47] {aka ACL, ATPCL, CLATP}, NCR3 (natural cytotoxicity triggering receptor 3) [NCBI Gene 259197] {aka 1C7, CD337, LY117, MALS, NKp30}, CPT2 (carnitine palmitoyltransferase 2) [NCBI Gene 1376] {aka CPT1, CPTASE, IIAE4}, LTB (lymphotoxin beta) [NCBI Gene 4050] {aka TNFC, TNFSF3, TNLG1C, p33}, HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2) [NCBI Gene 3158], RGS1 (regulator of G protein signaling 1) [NCBI Gene 5996] {aka 1R20, BL34, HEL-S-87, IER1, IR20}, ACACA (acetyl-CoA carboxylase alpha) [NCBI Gene 31] {aka ACAC, ACACAD, ACACalpha, ACC, ACC1, ACCA}, SOX13 (SRY-box transcription factor 13) [NCBI Gene 9580] {aka ICA12, Sox-13}, Klf2 (Kruppel-like transcription factor 2 (lung)) [NCBI Gene 16598] {aka Lklf}, FDPS (farnesyl diphosphate synthase) [NCBI Gene 2224] {aka FPPS, FPS, POROK9}, CD1C (CD1c molecule) [NCBI Gene 911] {aka BDCA1, CD1, R7}, HK2 (hexokinase 2) [NCBI Gene 3099] {aka HKII, HXK2}, Mcl1 (myeloid cell leukemia sequence 1) [NCBI Gene 17210] {aka Gm52627, Mcl-1}, KLRB1 (killer cell lectin like receptor B1) [NCBI Gene 3820] {aka CD161, CLEC5B, NKR, NKR-P1, NKR-P1A, NKRP1A}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, CXCR6 (C-X-C motif chemokine receptor 6) [NCBI Gene 10663] {aka BONZO, CD186, CDw186, STRL33, TYMSTR}, CCL5 (C-C motif chemokine ligand 5) [NCBI Gene 6352] {aka D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228}, Pcsk9 (proprotein convertase subtilisin/kexin type 9) [NCBI Gene 100102] {aka FH3, HCHOLA3, Narc1, PC9}, HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1) [NCBI Gene 3157] {aka CMYO28, HMGCS}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Cd28 (CD28 antigen) [NCBI Gene 12487], IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}
- **Diseases:** atherosclerotic plaque (MESH:D058226), stenosis (MESH:D003251), RPCA (MESH:C566443), necrotic (MESH:D009336), psoriasis (MESH:D011565), NK (MESH:D000077428), Staphylococcus aureus skin infection (MESH:D013203), infectious diseases (MESH:D003141), ATLOs (MESH:D000072717), ischemic attack (MESH:D002546), SLOs (MESH:D000092124), autoimmune (MESH:D001327), cytomegalovirus infection (MESH:D003586), inflammatory bowel disease (MESH:D015212), stroke (MESH:D020521), calcification (MESH:D002114), cancer (MESH:D009369), plaque calcification (MESH:D003773), gammadelta T (MESH:D003699), inflammation (MESH:D007249), rheumatoid arthritis (MESH:D001172), hyperlipidemia (MESH:D006949), carotid atherosclerotic (MESH:D002340), Carotid plaques (MESH:D016893), RLNs (MESH:D014388), atherogenic (MESH:D050197)
- **Chemicals:** PBS (MESH:D007854), cholesterol (MESH:D002784), ketamine hydrochloride (MESH:D007649), Lipid (MESH:D008055), xylazine hydrochloride (MESH:D014991), EDTA (MESH:D004492), isopentane (MESH:C067038), Fatty-acid (MESH:D005227), carbohydrates (MESH:D002241), fat (MESH:D005223), Visium HD (-), H&amp;E (MESH:D006371)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** C12 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0188), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), C8 — Homo sapiens (Human), Melanoma, Cancer cell line (CVCL_VV73), C5 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_M132)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12931092/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12931092/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12931092/full.md

---
Source: https://tomesphere.com/paper/PMC12931092